Trading Signals: AUTL Stock Price Prediction and Forecast (Fri. Jun. 22, 2018 - Fri. May. 13, 2022)(Autolus Therapeutics plc )
| AUTL latest price $3.4200 (-2.29%) ($3.4200 - $3.4200) on Sun. Apr. 24, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.59% (three month average) | RSI | 29 | Latest Price | $3.4200(-2.29%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | AUTL declines -3.2% a day on average for past five trading days. | Weekly Trend | AUTL declines -10.8% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support AUTL advance at 0% a week (0% probability) (0%) (0%) (0%) (0%) (0%) | Factors Impacting AUTL price | AUTL will decline at least -1.795% in a week (0% probabilities). (0%) (0%) (0%) (0%) (0%) | | | | | Relative Volatility | | | | Market Trend Strength | -1.795% (StdDev 3.59%) | Hourly BBV | 0 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-11.64(-440.35%) | Resistance Level | $4.1 | 5 Day Moving Average | $3.58(-4.47%) | 10 Day Moving Average | $3.86(-11.4%) | 20 Day Moving Average | $4.1(-16.59%) | To recent high | -26.9% | To recent low | 0% | Market Cap | $N/A | | | | Autolus Therapeutics Plc is a biopharmaceutical company. It engages in the development of cancer treatments. The firm's portfolio includes B Cell Malignancies, Multiple Myeloma, T Cell Lymphoma, GD2+ Tumors, and Prostate Cancer. The company was founded by Martin Pulé in February 2018 and is headquartered in London, the United Kingdom. |